New Report Finds Corporate R&D Budgets Increasing Amidst Pandemic
Global Newswire reported that InnoLead has released a new research report, “Retooling R&D for a New Era,” that explores emerging trends in R&D in Global 1000 companies. Among the findings the survey found that open innovation practices have moved into the mainstream. Forty-six percent of respondents say they use open innovation
Comments Off on New Report Finds Corporate R&D Budgets Increasing Amidst Pandemic • Read this story »
More Articles
Open Innovation in Drug Development
The Express Pharma website reported that the complexities involved in commercializing any new drug has led pharma companies to adopt a more open, collaborative approach for their research and development processes. There are several advantages to introducing open innovation for the drug creation process.
Comments Off on Open Innovation in Drug Development • Read this story »
Innovation Constraints: R&D role in Successful Innovation & Performance
The Journal of Business and Management posted a study on constraints to innovation which utilized qualitative data collected from extensive literature review and allowed for a robust discourse. Findings revealed that an obvious significant relationship exists between research and development, innovation,
Comments Off on Innovation Constraints: R&D role in Successful Innovation & Performance • Read this story »
AstraZeneca CEO Heralds New Era of Collaboration
The Cambridge Independent website reported that AstraZeneca CEO Pascal Soriot announced that the company’s advanced drug discovery robot, NiCoLA-B, will be housed in the biopharmaceutical company’s new £500million global research and development center, heralding a new era of openness and
Comments Off on AstraZeneca CEO Heralds New Era of Collaboration • Read this story »